Published in Biochim Biophys Acta on March 11, 1968
Evolution of alpha 2-macroglobulin. The demonstration in a variety of vertebrate species of a protein resembling human alpha 2-macroglobulin. Biochem J (1982) 1.06
Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses. J Clin Pathol (1977) 0.94
Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature. Am J Pathol (1984) 0.87
Substiuted sialic acid prosthetic groups as determinants of viral hemagglutination. J Virol (1969) 0.84
Reappearance of H1N1 influenza virus in man: evidence for the persistence of the virus in domestic chickens. Bull World Health Organ (1979) 0.76
Complete covalent structure of human beta-thromboglobulin. Biochemistry (1978) 2.64
The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen. Br J Haematol (1974) 1.70
Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res (1981) 1.54
The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta (1975) 1.37
The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res (1975) 1.31
The sialic acids of horse serum with special reference to their virus inhibitory properties. Biochim Biophys Acta (1968) 1.17
The multiple complexes formed by the interaction of platelet factor 4 with heparin. Biochem J (1980) 1.13
Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochim Biophys Acta (1975) 1.13
The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4. Thromb Res (1978) 1.11
Chromatography of human prothrombin complex or dextran sulphate agarose. Thromb Res (1977) 1.09
Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets. J Clin Invest (1983) 1.05
Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol (1976) 1.04
Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. Nat New Biol (1973) 1.00
Three approaches to the radioimmunoassay of human beta-thromboglobulin. Br J Haematol (1976) 0.99
Reductive amination for solid-phase coupling of protein. A practical alternative to cyanogen bromide. J Immunol Methods (1986) 0.99
Isolation of a macroglycopeptide from human platelets. Biochemistry (1970) 0.99
Lymphocyte, granulocyte and platelet contamination of blood frozen by the low-glycerol liquid nitrogen technique. Br J Haematol (1980) 0.96
The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost (1986) 0.96
The interaction between collagens and factor VIII/von Willebrand factor: investigation of the structural requirements for interaction. Thromb Res (1983) 0.96
A radioimmunoassay for platelet factor 4. Thromb Res (1976) 0.95
The in vivo release of human platelet factor 4 by heparin. Thromb Res (1982) 0.93
Studies on glycoproteins. 3. Isolation of sialylglycopeptides from human platelet membranes. Biochemistry (1969) 0.91
The absorption, clearance and metabolic fate of dermatan sulphate administered to man--studies using a radioiodinated derivative. Thromb Haemost (1989) 0.90
Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies. Thromb Haemost (1985) 0.89
A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res (1983) 0.89
The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen. Thromb Res (1975) 0.89
Human platelet factor 4 and tissue mast cells. Thromb Res (1981) 0.88
The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urine. Thromb Haemost (1985) 0.88
The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form. Thromb Res (1982) 0.87
The different forms of antithrombin II in serum. Thromb Haemost (1977) 0.87
Tandem purification of mouse IgM monoclonal antibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography. J Chromatogr (1986) 0.86
Isolation and properties of human vascular plasminogen activator. Thromb Haemost (1981) 0.86
Quantitation by radioimmunoassay of thrombospondin synthesised and secreted by human endothelial cells. Thromb Haemost (1984) 0.85
A comparison of methods for platelet lysis and the isolation of platelet membranes. Thromb Diath Haemorrh (1971) 0.85
Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Thromb Res (1986) 0.85
Neutralization of heparin in plasma by platelet factor 4 and protamine sulphate. Br J Haematol (1978) 0.85
Plasma and serum antithrombin - III: differentiation by crossed immunoelectrophoresis. Thromb Res (1975) 0.84
Monoclonal antibodies directed against human alpha-thrombin and the thrombin-antithrombin III complex. Thromb Res (1984) 0.84
A chromatographic procedure for the purification of influenza virus. J Gen Virol (1967) 0.84
Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route. Thromb Haemost (1992) 0.84
Immunoaffinity purification of factor VIII complex. Thromb Haemost (1987) 0.84
Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest. Thromb Diath Haemorrh (1975) 0.83
The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymers. Biochim Biophys Acta (1981) 0.83
Isolation of a glycoprotein fraction from human platelet membranes which inhibits viral haemagglutination. Nature (1968) 0.83
Plasma beta-thromboglobulin in diabetes mellitus. Diabetes (1977) 0.83
Low-resolution structure of the complex of human blood platelet factor 4 with heparin determined by small-angle neutron scattering. Biochim Biophys Acta (1986) 0.82
Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets. J Clin Pathol (1982) 0.82
A sensitive competitive binding assay for exogenous and endogenous heparins. Thromb Res (1982) 0.81
Metabolism of sodium pentosan polysulphate in man--catabolism of iodinated derivatives. Thromb Haemost (1984) 0.81
Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4). Br J Haematol (1992) 0.81
Protein modification during antiviral heat bioprocessing. Biotechnol Bioeng (2000) 0.81
Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism. Eur J Biochem (1986) 0.81
Evaluation of protein modification during anti-viral heat bioprocessing by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom (2001) 0.80
Properties of horse serum gamma inhibitor. Nature (1965) 0.80
Preliminary assessment of whole-blood, red-cell and platelet- leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing. Br J Haematol (1999) 0.80
Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo. Immunology (1990) 0.80
Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins. Thromb Haemost (1985) 0.79
Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process. Thromb Haemost (1981) 0.79
Pharmacokinetic and biological activities of dermatan sulfate (Mediolanum MF701) in healthy human volunteers. Ann N Y Acad Sci (1989) 0.78
Content and release of beta-thromboglobulin and platelet factor 4 in patients with qualitative platelet defects. Thromb Res (1979) 0.78
In vivo release of anti-Xa clotting activity by a heparin analogue. Thromb Res (1980) 0.78
Effect of different resuspension media on the post-thaw characteristics of frozen blood. Br J Haematol (1980) 0.78
Protein modifications during antiviral heat bioprocessing and subsequent storage. Biotechnol Prog (2001) 0.77
High molecular weight aggregate content of heated and unheated factor VIII products determined by fast-protein liquid chromatography. Vox Sang (1990) 0.77
In vitro tests of the potential thrombogenicity of factor IX concentrates: inhibition and characterisation studies of NAPTT, TGt50 and PF3 moieties. Thromb Res (1981) 0.77
Partial amino acid sequence of human beta-thromboglobulin: structural relationship with platelet factor 4. Thromb Res (1978) 0.77
Novel affinity chromatographic system for the single-step purification of glycosaminoglycans from complex systems using volatile buffers. J Chromatogr (1991) 0.76
Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma. Thromb Haemost (1993) 0.76
The development of aluminum containers for the storage of blood in liquid nitrogen for the immunization of Rh volunteers. J Clin Pathol (1973) 0.75
The Urinary Excretion of S Substance in Lobar Pneumonia. Yale J Biol Med (1934) 0.75
The distribution of carbohydrate in the plasmin resistant core fragments (D,E) of human fibrinogen. Biochim Biophys Acta (1974) 0.75
Hemoglobin polymerization. Methods Enzymol (1994) 0.75
Investigations on antithrombin III in normal plasma and serum. Br J Haematol (1975) 0.75
Multivalent proteins and multidentate polysaccharides: interaction of platelet factor 4 and heparin. Biochem Soc Trans (1981) 0.75
Proceedings: Isolation and characterization of human platelet beta-thromboglobulin. Thromb Diath Haemorrh (1975) 0.75
Proceedings: The identification of two platelet specific release products. Br J Haematol (1974) 0.75
Influence of platelet factor 4 on inhibited thrombin substrate reactions. Thromb Res (1974) 0.75
Direct dye binding--a quantitative assay for solid-phase immobilized protein. Anal Biochem (1992) 0.75
Proceedings: Improvements in frozen blood stored in liquid nitrogen. Br J Haematol (1974) 0.75
Chromatographic and electrophoretic properties of synthetic human fibrinopeptides. Thromb Diath Haemorrh (1974) 0.75
Quantitation of expression of idiotopes recognized by a panel of monoclonal antibodies in normal serum immunoglobulin: use of a novel 4-stage ELISA assay. J Clin Lab Immunol (1989) 0.75
Heparin and blood coagulation. Thromb Haemost (1976) 0.75
Half-life of platelet factor 4 (PF-4) in plasma and platelets from macaca mulatta. Thromb Haemost (1977) 0.75
Chemotactic activity of fibrinopeptides. Nouv Rev Fr Hematol (1975) 0.75
Development, optimization and use of an enzyme linked immunosorbent assay (ELISA) to measure factor VIII antigen utilizing monoclonal antibodies. Transfus Med (1992) 0.75
The interaction of platelet factor 4 with heparins of different chain length. Biochim Biophys Acta (1984) 0.75
In vitro thrombogenicity tests of factor IX concentrates. Br J Haematol (1977) 0.75
In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin. Thromb Haemost (1980) 0.75
Dual purpose light scattering and centrifuge cell for the production of dust free solutions. Lab Pract (1973) 0.75
Selection of monoclonal antibodies for immunoaffinity chromatography: model studies with antibodies against soy bean trypsin inhibitor. J Biochem Biophys Methods (1991) 0.75
Hypotensive effects of stroma-free haemoglobin solutions attributable to adenine nucleotides. Transfus Med (1991) 0.75
Structural and immunological differences between human platelet and endothelial thrombospondins. FEBS Lett (1986) 0.75
beta-thromboglobulin and deep vein thrombosis. Thromb Haemost (1978) 0.75
Rubber glove hygiene. Br Dent J (1987) 0.75
Macromolecules released from platelet storage organelles. Thromb Haemost (1980) 0.75
The use of human endothelial cells cultured in flat wells and on microcarrier beads to assess tissue plasminogen activator and factor VIII related antigen release. Thromb Res (1986) 0.75
Newer techniques in the study of hemostatic disorders. Semin Hematol (1978) 0.75
Thrombogenicity screening of factor IX concentrates. Thromb Haemost (1977) 0.75
Detection of thrombin-antithrombin III complex by crossed immunoelectrophoresis. Thromb Res (1976) 0.75
Spectrophotometric determination of factor Xa generation in factor IX concentrates. Thromb Haemost (1977) 0.75